Issue Date: February 6, 2012
Ceres Files IPO Worth $132 Million
Ceres, a plant biotechnology start-up, hopes to raise as much as $132 million in an initial public offering of stock, according to filings with the Securities & Exchange Commission. The company has developed dedicated crops for use as bioenergy feedstocks, including sorghum, switchgrass, and miscanthus, using traditional breeding as well as genetic engineering. Monsanto has licensed corn and soybean traits from Ceres and owns a 6.2% stake in the company.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society